Medically reviewed by Nicholas R. Metrus, MD Multiple sclerosis (MS) and amyotrophic lateral sclerosis (ALS, also called Lou Gehrig's disease) are both diseases that affect your central nervous system ...

BCLI READ THE FULL BCLI RESEARCH REPORT Business Update Focused on Advancing NurOwn into Phase 3b ENDURANCE Trial BrainStorm ...

Amyotrophic lateral sclerosis (ALS) is a widespread neurodegenerative disease caused by the loss of neurons that control movement. Although abnormal accumulation of proteins called TDP-43 ...

Increased consumer and medical professional knowledge regarding novel treatments is predicted to drive growth in the global amyotrophic lateral sclerosis (ALS) treatment market. The introduction ...

"New therapeutic strategy to reduce neuronal death in amyotrophic lateral sclerosis." ScienceDaily. ScienceDaily, 16 November 2023. <www.sciencedaily.com / releases / 2023 / 11 / 231116141023.htm>.

The Food and Drug Administration (FDA) has granted accelerated approval to Qalsody ™ (tofersen) for the treatment of adults with amyotrophic lateral sclerosis (ALS) who have a mutation in the ...

• Key Amyotrophic Lateral Sclerosis Pipeline Therapies: ION363, FB418, SRK-015, RNS60, QRL-201, SAR443820, MN-166, VM202, VRG-50635, Zilucoplan, and others.

Long-term exposure to sulfur dioxide, an air pollutant generated by the burning of fossil fuels, increases the risk of ALS, a ...